MDT
82.86
-5.69%↓
VEEV
213.67
-3.6%↓
A
100.51
-8.39%↓
HQY
76.5
-7.7%↓
PDCO
30.94
-0.83%↓
MDT
82.86
-5.69%↓
VEEV
213.67
-3.6%↓
A
100.51
-8.39%↓
HQY
76.5
-7.7%↓
PDCO
30.94
-0.83%↓
MDT
82.86
-5.69%↓
VEEV
213.67
-3.6%↓
A
100.51
-8.39%↓
HQY
76.5
-7.7%↓
PDCO
30.94
-0.83%↓
MDT
82.86
-5.69%↓
VEEV
213.67
-3.6%↓
A
100.51
-8.39%↓
HQY
76.5
-7.7%↓
PDCO
30.94
-0.83%↓
MDT
82.86
-5.69%↓
VEEV
213.67
-3.6%↓
A
100.51
-8.39%↓
HQY
76.5
-7.7%↓
PDCO
30.94
-0.83%↓
24h
Current
Min
4.9
Max
5.67
Income | -41M -65M |
---|---|
Profit margin | -82.56 |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +142.25% upside |
Next Earnings | 7 maj 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
31 gru 2024, 19:15 UTC
Verastem Shares Soar on FDA Priority Review of Cancer Treatment
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 12.5 USD 142.25%
High 20 USD
Low 9 USD
Based on 8 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
8 ratings
8
Buy
0
Hold
0
Sell
Based on 8 analysts giving stock ratings to Verastem Inc - Dist in the past 3 months.
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$